CRNH’s Historical context

Slides:



Advertisements
Similar presentations
06/02/ Mechanisms to enhance synergy between ERA-NETs within and between research councils Eili Ervelä-Myréen
Advertisements

COMMUNITY INTERVENTIONS AND CAPACITY BUILDING FOR NON-COMMUNICABLE DISEASE PREVENTION AND CONTROL IN TUNISIA AND NORTH AFRICA Pr Hassen Ghannem Department.
The French National Alliance for Life Sciences and Health AVIESAN Prof. André Syrota Chairman and CEO of Inserm President of Aviesan STOA, Brussels, June.
3 rd International Biomedical Research Meeting June 10 th 2011 Résidence de Marigny Pr André Syrota.
Housing and Health Advocacy: The role of Health Professionals Pediatric Advocacy Grand Rounds Dr. Lindy Samson – Paediatric Infectious Diseases Specialist.
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
METHODS The FETRIC project is targeted to some identified shortcomings and gaps; for example: lack of links and understanding between the research community.
Oficina AproTECH de AETIC: Información y asesoramiento en la preparación de propuestas de I+D+I The structure of the FP7: Funding schemes,
I NNO M OL ENHANCEMENT OF THE INNOVATION POTENTIAL IN SEE THROUGH NEW MOLECULAR SOLUTIONS IN RESEARCH AND DEVELOPMENT.
Nutrition Research and the NIH Roadmap
Combating major diseases Gender aspects in research Gender aspects in research have a particular relevance to this theme as risk factors, biological mechanisms,
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
Agency for Health Protection and Promotion Core Indicators and Ontario’s Agency for Health Protection and Promotion Dr Natasha S. Crowcroft Director, Surveillance.
The Value of Networking in Allergy & Asthma Research Judah A. Denburg, MD, FRCP(C) Scientific Director and CEO The Allergy Genes and Environment Network.
A L I M E N T A T I O N A G R I C U L T U R E E N V I R O N N E M E N T INRA: for the Earth and for Man Public mission oriented research Sustainable agriculture.
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
Rare Diseases Foundation Céline Hubert Pr Nicolas Lévy
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
Institute of Cancer Research - Institut du cancer ICR’s Activities in Cancer Imaging.
EMERGING AND RE-EMERGING INFECTIOUS DISEASES: A CONTINUOUS CHALLENGE FOR EUROPE STOA - AVIESAN Workshop June 19th 2012, European Parliament, Bruxelles.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
05/09/2015www.ecrin.org1 European Clinical Research Infrastructures Network
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
1 Karolinska University Hospital. –Presentation Heikki Teriö, FoU-manager Education:Applied Physics and Electronics Linkoping University of Technology.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Lis Nielsen, Ph.D. Division of Behavioral and Social Research (BSR) National Institute on Aging NIA/IPSR Workshop: Advancing Integrative.
The National Institute for Agronomic Research  Set up in 1946  A public, scientific and technological establishment  Under the joint authority of the.
Image 1 – Tomato seedling iStockphoto/Thinkstock, Image 2 – Fermenter iStockphoto/Thinkstock 2011, Image 3 – Wheat Hermerara/Getty Images, Image 4 –DNAConfig.
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
1 Research Infrastructures in FP7 EUDET Annual Meeting 19 October 2006, Munich Dr. Gerburg Larsen European Commission, RTD-B.3 - Research Infrastructures.
Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.
1 Common Challenges Across Scientific Disciplines Laurence Field CERN 18 th November 2013.
Medicines for Children Research Network Paediatric Clinical Trials: Principles, Practicality and the Medicines for Children Research Network Andrew Collinson.
The European Institute of Innovation and Technology (EIT) Georgi Dimitrov, European Commission TCI Annual Conference 2010 Facilitating global outreach.
Telematikplattform für Medizinische Forschungsnetze (TMF) e.V. TMF – A Common Platform for Medical Research Networks in Germany Improving the Organisation.
Vision and Aims Chalmers AoAs should use our scientific excellences to meet the global grand challenges where we can make a difference The AoAs aims to.
European Commission Introduction to the Community Programme for Employment and Social Solidarity PROGRESS
Federation for Healthcare Science (FHCS). Scientific/Technical/Therapy 10% NHS workforce data 2003: Total of 1.3M people employed 1.1M of these involved.
Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.
2 Global Pit: An Inter-disciplinary Global Health Centre World Health Organization Collaborating Centre University of Pittsburgh Supercourse team.
Send correspondence to: Bartha Maria Knoppers Chair of Interim Board Centre de recherche en Droit Public Université de Montréal.
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
RMIT University© 1 Health Innovations Research Institute (HIRi) Translating fundamental science into.
Consortium for Interdisciplinary Studies on Science for Aging.
EURORDIS Eurordis Position on Research Priorities for Rare Diseases.
Shaping a Health Statistics Vision for the 21 st Century 2002 NCHS Data Users Conference 16 July 2002 Daniel J. Friedman, PhD Massachusetts Department.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
JPI - A HEALTHY DIET FOR A HEALTHY LIFE. EUROPE: diversity and fragmentation.
Vaccine Enterprise & Collaboration Bill Snow, Director 19 January 2013 CHVI Afri-Can Forum.
EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.
Practical Aspects of Preparation FP 6 projects Senter/EG-Liaison Nationaal Contact Punt voor het 6de Kaderprogramma Sandra de Wild 11 december 2002.
NCB Noël Barengo, MD, PhD, MPH Department of Public Health University of Helsinki, Finland Unit of Clinical Research, University Hospital La Paz,
NIHR Southampton Biomedical Research Centre The Southampton Biomedical Research Centre is funded by the National Institute for Health Research (NIHR) and.
I farmaci innovativi in una prospettiva europea Giuseppe M.C. Rosano, MD, PhD Cardiovascular and Cell Sciences Research Institute, St George's University.
Joint programming Initiatives: The development of a SRA.
Professor Orla Hardiman HRB Clinician Scientist Innovation Its role in Delivering Better Health Outcomes.
K. Zatloukal The European Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI) Kurt Zatloukal, Medical University of Graz, Austria.
IADSA Scientific Forum 2009 The scientific substantiation of health claims David P. Richardson Scientific Adviser to UK Council for Responsible Nutrition.
Anne Cambon-Thomsen, MD,
Science for Life Laboratory
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Action: BM0806 Recent Advances in Histamine Receptor H4R Research
Cardiovascular Diseases Faculty of Medicine Second Annual Retreat
HPH Strategy Seminar Beijing, China 7 september 2013 Andrea Limbourg
Clinical and Translational Science Awards Program
Overview of Clinical & Translational Penn
The International Consortium for Personalised Medicine
Trial Funding and Engagement: The NIH Sponsored CTSA Program
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Presentation transcript:

CRNH’s Historical context

Maurice Arnal Bernard Beaufrere Xavier Leverve

Created in 2003 Created 1995 Created in 1992 Created in 1996

Aims Coordination and development of research in nutrition Bench to bedside: molecular and cellular level to clinical research including epidemiological studies Collaborations with industrial partners to improve the quality of food for health purpose. Bring together all the tools and knowledge required for Nutrition Research in well-defined internationally renowned locations. Role in education and as an expert body.

Organisation Administration Director and associate director Administrative council Scientific council Partners Research Institutes INRA INSERM Universities Hospitals Others, dependent on local facilities

Common Tools

Clinical investigation centres

Mass spectrometry centres

Genetics, genomics, proteomic, metagenomic facilities

Nutritional survey and intervention in cohorts

Global approach

Regional role of CRNH Development of local research in human Nutrition by bringing tools, methodology and knowledge in human nutrition and building bridges between different communities’ -Basic researchers -Physicians -Engineers -Sociologist, economist -food industry Important role in the organisation of research in nutrition with a critical mass of scientist in large INRA or INSERM units.

CRNH’s A big potential of more than 450 p (PhD, MD, University professors, 80 researchers with h factors more than 20 ) Annual global budget around 4 Millions € High out put of highly-cited international publications Complementary and synergy of tools and research fields Possibility of multicentres studies Exchange of knowledge and competency Application to national and international calls…

CRNH’s How to promote CRNH’s?

Institutional Partners Research Institute: INSERM. INRA. University : Lyon 1. J. Fourier Grenoble. J. Monnet Saint Etienne. Hospital : Hospices Civils de Lyon. CHU Grenoble. CHU ST Etienne. A Critical Mass 200 people 5 research Units 25 Hospital Departments

CRNH –RA teams Nutrition & Diabetes Lipid Metabolism Hospital departments Diabetology Nutrition, Nephrology Paediatrics Geriatrics Intensive care, Bariatric surgery Transplantation surgery Biochemistry Pharmacy Team 1 : H. Vidal/ M. Laville Nutritional adaptations, Environment and Diabetes Team 4 : M. Lagarde/ Ph. Moulin/ MC Michalski Engineering and Functions of Lipids and Lipoproteins Team 2 : E. Lefai/ C. Simon Regulation of Muscle Mass and Metabolic Diseases Team 3 : J. Rieusset/ C. Thivolet Glucolipotoxicity, Metabolic Stress and Diabetes 21

CRNH –RA teams University of Lyon University of Grenoble - Centre de Recherche en Neurosciences de Lyon U1028 / UMR 5292 Team: Waking - Integrative Physiology of Brain Arousal Systems , Leader : K. Spiegel University of Grenoble - Physiopathology Cardiovascular and Respiratory (HP2) Inserm U 1042, Leaders: P. Levy, JL Pepin, AL Borel - Laboratory of Applied and Fundamental Bioenergetics (INSERM 1055) Team: “bioenergetics and metabolism Leader: E. Fontaine University of Saint Etienne - EA 4607- SNA (autonomous nervous system), Team: Anorexia nervosa and constitutional thinness, Leader: B. Galusca Departments of Pneumology, Endocrinology and Nutrition Departments of Endocrinology-Nutrition 22

Characterization of environment GPS, accélérometre, magnetomètres, inclinomètre, fréquence cardiaque Pollutants, Gut microbiota Socio-economic context Session A Session B Bastian et al. EASD 2012 Allirot, Appetite, 2012, 58:889-897 Dietary intake Sedentarity Casey, IJO, 2012,36, 914-919

Accurate phenotyping Metabolic investigations Substrate fluxes Platforms : clinical investigation, omics, imaging, mass spectrometry clinical biological imaging Metabolic investigations Substrate fluxes

Translational research Tissu biopsies Tissu adipeux, muscle, feces… Alligier, JCEM, 2012 D0 D56 Nutritional interventions Link with animal models and human cell cultures Bonnard, JCI, 2008 Therapeutic applications

Randomised control trials Randomised trial Control or placebo Product/diet Patient or healthy subjects We have also to respect the rCT rules and to solve many problems, how can we blind, what is a placebo in nutrition, what are the relevant health outcomes are intemediary biomarkers valuable, how to validate them? Shuld we go to long term trails with morbi mortality endpoints and the predimed study is a good exemple, and in which population at risk or healhy subjects… We should answer this question if we want to reply to this kind of agressive editorial! Relevant endpoints Short term : biomarkers, long term: morbi-mortality??? Validation of hypothesis

CRNH RA a powerful actor of development 27

Opening to society and international networking CENS is a consortium of scientists and clinicians specialised in nutrition, together with industrial partners to address health and societal challenges at an international level and sharing the same vision to provide an available and affordable healthy lifestyle to the general population. 28

Missions Help for collaborative projects Transmission of knowledge In 2016, A new 6000-m2 building dedicated to clinical and clinical research and collaborative projects Networking and promotion of scientist, clinician and industrial skills

CRNH-RA an important role in obesity research organisation FORCE DO-IT DO-IT : Dialogs in Obesity and Innovative Therapeutics University-Hospital Federation (Lyon1 university- Hospices Civils de Lyon) FORCE : French Obesity Research Centres of Excellence labeled by FCRIN : Paris, Lyon, Toulouse

CRNH-RA a role in EU Infrastructure initiatives DEDIPAC Rhône_ Alpes

EuroDISH Determinants, Intake, Status, Health Study on the need for food and health research infrastructures in Europe EuroDISH Determinants, Intake, Status, Health Conceptual model of the causal chain of food & health research, helpful for organizing the research area

structuring pan-European investigation networks ECRIN-IA (2012-15): structuring pan-European investigation networks European Clinical Research Infrastructure Network ECRIN is listed on the ESFRI (European Strategy Forum on Research Infrastructures) roadmap and is the pan-European distributed infrastructure designed to support multinational clinical research, making Europe a single area for clinical studies, taking advantage of its population size to access patients, and unlocking latent scientific potential.

Nutrition hub based in Lyon 73 centres in 18 countries

CRNH Rhône-Alpes Centre Hospitalier Lyon Sud 165 chemin du Grand Revoyet 69310 PIERRE BENITE Tel : 04 78 86 29 81 E-mail : secretariat.crnh(@)chu-lyon.fr www.crnh.fr